D-Index & Metrics Best Publications

Gil D. Rabinovici

University of California, San Francisco
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 83 Citations 29,556 402 World Ranking 10340 National Ranking 5424

Overview

What is he best known for?

The fields of study Gil D. Rabinovici is best known for:

Alzheimer's disease
Dementia
Hippocampus

His study in Cognitive impairment extends to Disease with its themes. His research on Cognitive impairment often connects related topics like Disease. As part of his studies on Pathology, Gil D. Rabinovici frequently links adjacent subjects like Amyloid (mycology). Gil D. Rabinovici combines topics linked to Pathology with his work on Amyloid (mycology). Gil D. Rabinovici merges many fields, such as Dementia and Posterior cortical atrophy, in his writings. Gil D. Rabinovici performs integrative Posterior cortical atrophy and Dementia research in his work. His work in Neuroscience is not limited to one particular discipline; it also encompasses Hippocampus. Gil D. Rabinovici frequently studies issues relating to Neuroscience and Hippocampus. In his papers, he integrates diverse fields, such as Alzheimer's disease and Primary progressive aphasia.

His most cited work include:

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria (2376 citations)
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria (1146 citations)
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins (935 citations)

What are the main themes of his work throughout his whole career to date

His Frontotemporal dementia research is covered under the topics of Frontotemporal lobar degeneration and Primary progressive aphasia. His work often combines Primary progressive aphasia and Frontotemporal dementia studies. His research combines Progressive supranuclear palsy and Disease. His Progressive supranuclear palsy study frequently draws parallels with other fields, such as Disease. In most of his Pathology studies, his work intersects topics such as Amyloid (mycology). Many of his studies involve connections with topics such as Pathology and Amyloid (mycology). His Dementia study typically links adjacent topics like Cognitive decline. His Cognitive decline study frequently draws connections to other fields, such as Dementia. Gil D. Rabinovici conducted interdisciplinary study in his works that combined Neuroscience and Neuroimaging.

Gil D. Rabinovici most often published in these fields:

Disease (86.80%)
Pathology (73.60%)
Dementia (63.96%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel.
Lancet Neurology (2014)

2859 Citations

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

Sandip Ray;Markus Britschgi;Charles Herbert;Yoshiko Takeda-Uchimura.
Nature Medicine (2007)

1229 Citations

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

Bruno Dubois;Harald Hampel;Harald Hampel;Howard H. Feldman;Philip Scheltens.
Alzheimers & Dementia (2016)

1218 Citations

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

Günter U Höglinger;Gesine Respondek;Maria Stamelou;Carolin Kurz.
Movement Disorders (2017)

1086 Citations

Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease

Juan Zhou;Michael D. Greicius;Efstathios D. Gennatas;Matthew E. Growdon.
Brain (2010)

920 Citations

PET Imaging of Tau Deposition in the Aging Human Brain

Michael Schöll;Michael Schöll;Samuel N. Lockhart;Daniel R. Schonhaut;James P. O’Neil.
Neuron (2016)

855 Citations

Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

Rik Ossenkoppele;Rik Ossenkoppele;Rik Ossenkoppele;Daniel R. Schonhaut;Daniel R. Schonhaut;Michael Schöll;Michael Schöll;Samuel N. Lockhart.
Brain (2016)

780 Citations

Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects

E. C. Mormino;J. T. Kluth;C. M. Madison;G. D. Rabinovici;G. D. Rabinovici;G. D. Rabinovici.
Brain (2009)

712 Citations

Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.

Gil D. Rabinovici;Bruce L. Miller.
CNS Drugs (2010)

567 Citations

Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease

Keith A. Vossel;Alexander J. Beagle;Gil D. Rabinovici;Huidy Shu;Huidy Shu.
JAMA Neurology (2013)

539 Citations

If you think any of the details on this page are incorrect, let us know.